Autoimmunity: Genes, Triggers and the Functional Medicine Perspective

Autoimmune diseases are individually diverse, from type 1 diabetes and multiple sclerosis to rheumatoid arthritis, coeliac disease, lupus and autoimmune thyroid disease. Together they are common, often chronic and increasing in incidence in many countries. They share a central feature: the immune system, designed to distinguish self from non self, loses its tolerance to the body’s own tissues. Understanding why this happens, and what influences it, helps practitioners support patients while respecting the essential role of specialist treatment.

How common it is

A large study using health records from millions of people in the United Kingdom found that 19 of the most common autoimmune diseases together affected around 1 in 10 people, with women affected roughly twice as often as men. Several autoimmune diseases have become more common over recent decades, a trend too rapid to be explained by genetics alone and pointing to environmental factors.

The basic mechanism

Autoimmunity develops when self reactive immune cells escape or overcome the mechanisms that normally keep them in check. Self reactive T and B cells exist in everyone; tolerance normally prevents them from causing harm. Disease results when a combination of genetic susceptibility, environmental triggers and failures of regulation allows these cells to become activated and sustain an attack on a particular tissue.

Once established, autoimmune responses tend to be self perpetuating: tissue damage releases more self antigens, which fuel further immune activation, and the response can spread to new targets over time.

Genes

Autoimmune diseases run in families, and people with one autoimmune disease are more likely to develop another. The strongest genetic associations are with genes of the human leukocyte antigen system, which control how antigens are presented to T cells. For example, almost all people with coeliac disease carry particular HLA types. Many other genes involved in immune regulation contribute smaller effects. Genetic susceptibility is necessary but rarely sufficient: identical twins frequently differ in whether they develop the same autoimmune disease.

Environmental triggers with strong evidence

Factors under investigation

• Vitamin D: low levels are associated with several autoimmune diseases, and an analysis of a large trial found fewer autoimmune disease diagnoses in people given vitamin D over several years.
• The microbiome: differences in gut microbes are reported in many autoimmune diseases, and microbes influence immune regulation; causal roles are being investigated.
• Obesity: associated with increased risk of several autoimmune conditions.
• Psychological stress and trauma: a large cohort study found that people diagnosed with stress related disorders had a higher subsequent risk of autoimmune disease.
• Diet: Western dietary patterns, high salt intake and ultra processed foods have been proposed as contributors, with mixed evidence.
• Intestinal permeability: increased in some autoimmune diseases, with its causal role uncertain outside specific conditions such as coeliac disease.

A long preclinical phase

Many autoimmune diseases develop silently for years. In lupus, autoantibodies have been detected in stored blood samples many years before diagnosis, appearing in a characteristic sequence. In rheumatoid arthritis and type 1 diabetes, autoantibodies also precede clinical disease. This preclinical phase is an active area of research into prevention: in type 1 diabetes, a medicine has been approved in some countries to delay the onset of clinical disease in people with autoantibodies.

Why early specialist treatment matters

For many autoimmune diseases, early treatment prevents irreversible damage. In rheumatoid arthritis, there is a window of opportunity in the first months after symptom onset during which disease modifying treatment is most effective at preventing joint destruction. In multiple sclerosis, early disease modifying therapy reduces relapses and disability. Delaying diagnosis or treatment in favour of alternative approaches can cause lasting harm. The integrated practitioner’s role is to support specialist care, not to substitute for it.

A functional perspective

Functional medicine asks what triggered the disease and what sustains it. For autoimmune disease, this means considering:

1. The timeline: infections, pregnancy, major stress, new medicines, exposures or significant life events around the onset.
2. Modifiable mediators: smoking, obesity, sleep, stress, physical activity, diet quality.
3. Nutritional status: vitamin D, iron, B12 and other deficiencies, some caused by the disease or its treatment.
4. Associated autoimmune conditions, which are more common in people with one autoimmune disease.
5. Treatment support: helping patients understand and adhere to their prescribed treatment, manage side effects in partnership with their specialist and monitor nutritional consequences, such as folate with methotrexate or bone health with glucocorticoids.

Diet and autoimmunity

Patients frequently ask whether diet can control their disease. The evidence varies by condition.

• In coeliac disease, a strict gluten free diet is the treatment.
• In rheumatoid arthritis, Mediterranean style diets and omega 3 fatty acids have modest benefits in some trials, as adjuncts to medical treatment.
• Autoimmune protocol diets, which eliminate many foods and then reintroduce them, have shown improvements in small, uncontrolled studies in inflammatory bowel disease and autoimmune thyroiditis; controlled evidence is lacking, and nutritional adequacy must be protected.
• For most autoimmune diseases, a nutritious, anti inflammatory dietary pattern that supports overall health is reasonable, without claims that it treats the disease.

An illustrative case

A 38 year old woman has developed painful, swollen joints in her hands over 3 months with morning stiffness lasting 2 hours. She smokes and has read that an elimination diet can reverse arthritis, and would like to try it before seeing a specialist. The practitioner recognises features of inflammatory arthritis and urges prompt referral, explaining the window for early treatment. Blood tests show positive rheumatoid factor and anti citrullinated protein antibodies, and she starts disease modifying treatment with a rheumatologist. The practitioner supports her to stop smoking, which improves response to treatment, helps her adopt a Mediterranean style diet, checks her folate and vitamin D and supports her through side effects. A year later her disease is in remission and her joints are undamaged.

Understanding and partnership

Autoimmune disease reflects the meeting of genes and environment, and some of the environmental influences can be modified. Practitioners can help patients understand their condition, address triggers and mediators, and protect their overall health, always in partnership with the specialist treatment that prevents lasting damage.